Societies Implore Scientists to Write About Data-Release Rule

The Joint Steering Committee for Public Policy (JSC), a coalition of four basic biomedical research societies whose mission is to advocate federal funding for basic biomedical research, has asked scientists to respond to a recently proposed Fiscal Year 1999 Freedom of Information Act provision. The seemingly minor addition to last year's omnibus budget bill threatens to have a negative impact on scientific research (E. Russo, "Does accountability legislation threaten integrity of U.S. research

Written byEugene Russo
| 1 min read

Register for free to listen to this article
Listen with Speechify
0:00
1:00
Share

The Joint Steering Committee for Public Policy (JSC), a coalition of four basic biomedical research societies whose mission is to advocate federal funding for basic biomedical research, has asked scientists to respond to a recently proposed Fiscal Year 1999 Freedom of Information Act provision. The seemingly minor addition to last year's omnibus budget bill threatens to have a negative impact on scientific research (E. Russo, "Does accountability legislation threaten integrity of U.S. research enterprise?" The Scientist, 13[4]:1, Feb. 15, 1999).

By requiring federal agencies to publicly release all data generated in federally funded biomedical research, even if prior to peer review or publication, the legislation could endanger confidentiality of research subjects in clinical trials, and jeopardize relations between academic institutions and private businesses. Despite attempts by the government's Office of Management and Budget (OMB) to reduce the potential negative impact of the proposed regulations in a revision, the JSC warns ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member? Login Here

Meet the Author

Published In

Share
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies